<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">The failures in the laboratory synthesis of quinine greatly motivated researches for the prospection of new antimalarial drugs such as Amodiaquine, Primaquine, Proguanil, Pyrimethamine, and Chloroquine (Boss et al. 
 <xref ref-type="bibr" rid="CR17">2003</xref>; Ockenhouse et al. 
 <xref ref-type="bibr" rid="CR69">2005</xref>; Silva et al. 
 <xref ref-type="bibr" rid="CR85">2005</xref>). Chloroquine has been highlighted among these drugs due to its efficiency, low production costs, low toxicity, and the possibility of being consumed by pregnant women. These advantages made chloroquine the first choice in the treatment of malaria (Robert et al. 
 <xref ref-type="bibr" rid="CR76">2001</xref>; Silva et al. 
 <xref ref-type="bibr" rid="CR85">2005</xref>).
</p>
